paris saponin vii has been researched along with beta-escin in 14 studies
| Studies (paris saponin vii) | Trials (paris saponin vii) | Recent Studies (post-2010) (paris saponin vii) | Studies (beta-escin) | Trials (beta-escin) | Recent Studies (post-2010) (beta-escin) |
|---|---|---|---|---|---|
| 18 | 0 | 16 | 14,137 | 211 | 6,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, YW; Fu, YL; Ma, BP; Tang, XM; Wang, S; Yu, ZY; Yuan, XL; Zhao, Y | 1 |
| Fan, L; Han, J; Li, Y; Mei, Q; Meng, J; Miao, X; Sun, Y; Yue, Z; Zhang, D; Zhang, F; Zhang, R | 1 |
| Du, LW; Feng, JG; Jiang, H; Li, JH; Ma, SL; Song, SC; Zhao, PJ; Zhou, GH; Zhu, XH | 1 |
| Bi, H; Cheng, G; Gao, F; Sun, X; Zhu, Y | 1 |
| Hu, G; Jia, J; Sun, X; Wang, A; Yan, T; Yu, X | 1 |
| Jin, H; Li, X; Li, Y; Mei, Q; Niu, Y; Sun, Y; Tang, T; Xie, M | 1 |
| Duan, X; Fan, L; Li, Y; Mei, Q; Sun, Y; Tang, Y; Zheng, H; Zhou, H | 1 |
| Chen, B; Qi, Z; Qian, S; Tian, L; Tong, S; Wu, J; Zhang, Y; Zhu, D | 1 |
| Li, Y; Niu, YX; Tang, GE; Wang, XY; Wu, CY; Zhang, J | 1 |
| Gajendran, B; Li, Y; Lin, X; Liu, H; Liu, W; Ni, W; Qin, X; Qiu, J; Rao, Q; Song, J; Varier, KM; Wang, C; Wen, M | 1 |
| Cheng, Y; Mei, QB; Sun, Y; Ye, WL; Zhang, BL; Zhang, X; Zhou, SY | 1 |
| Liu, XW; Liu, Y; Lu, JF; Shen, J; Si, Y; Wen, J; Xiang, K; Xiang, YC; Yu, QQ; Zhang, L; Zhang, T | 1 |
| Jin, X; Liu, XW; Liu, Y; Peng, P; Ren, YL; Shen, J; Si, Y; Wan, F; Xiang, YC; Yu, QQ; Zhang, L; Zhang, T; Zhao, HZ | 1 |
| Bai, S; Cheng, Y; Ji, Q; Jiang, C; Liu, D; Liu, M; Mei, Q; Sun, Y; Ye, W; Zhang, B; Zhou, S | 1 |
14 other study(ies) available for paris saponin vii and beta-escin
| Article | Year |
|---|---|
Pennogenin glycosides with a spirostanol structure are strong platelet agonists: structural requirement for activity and mode of platelet agonist synergism.
Topics: Animals; Bleeding Time; Blood Platelets; Cyclic AMP; Glycosides; Male; Mice; Mice, Inbred BALB C; Models, Chemical; Platelet Aggregation; Saponins; Signal Transduction; Spirostans; Steroids | 2008 |
Paris saponin VII from trillium tschonoskii reverses multidrug resistance of adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition and apoptosis augmentation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Saponins; Structure-Activity Relationship; Trillium; Tumor Cells, Cultured | 2014 |
Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diosgenin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Gefitinib; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Radiation Tolerance; Radiation-Sensitizing Agents; Saponins | 2016 |
Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Osteosarcoma; Saponins; Trillium | 2016 |
Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle Checkpoints; Cell Proliferation; Humans; K562 Cells; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Saponins | 2018 |
Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Saponins; Trillium; Tumor Burden | 2019 |
Paris saponin VII extracted from trillium tschonoskii suppresses proliferation and induces apoptosis of human colorectal cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Colorectal Neoplasms; HCT116 Cells; HT29 Cells; Humans; Interleukin-6; Male; Mice; Mice, Nude; Saponins; STAT3 Transcription Factor; Trillium | 2019 |
Paris saponin VII extracted from Trillium tschonoskii induces autophagy and apoptosis in NSCLC cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Saponins; Trillium | 2020 |
Paris saponin VII enhanced the sensitivity of HepG2/ADR cells to ADR via modulation of PI3K/AKT/MAPK signaling pathway.
Topics: Apoptosis; Doxorubicin; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction | 2020 |
Paris Saponin VII Induces Apoptosis and Cell Cycle Arrest in Erythroleukemia Cells by a Mitochondrial Membrane Signaling Pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Erythroblastic, Acute; Mitochondrial Membranes; Molecular Structure; Plant Extracts; Saponins; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Biopharmaceutics classification evaluation for paris saponin VII.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestine, Small; Permeability; Rats; Saponins; Solubility | 2020 |
Paris saponin VII, a direct activator of AMPK, induces autophagy and exhibits therapeutic potential in non-small-cell lung cancer.
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Saponins | 2021 |
Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
Topics: Animals; Autophagy; Breast Neoplasms; Cell Proliferation; Female; Hippo Signaling Pathway; Humans; Mice; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Saponins | 2022 |
MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium Phosphates; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Mice; Mice, Nude; Nanoparticle Drug Delivery System; Nanoparticles; Pectins; Saponins | 2021 |